Losan Pharma, a privately owned, international operating CDMO meeting the hightest standard of global quality requirements, is providing solutions to enhance bioavailability, improve the stability of APIs and provide targeted, sustained release delivery of pharmaceutical products. We are glad to inform you that we have implemented several innovative technologies which could help you in the design
Teil 3 der Nanostory über eine neue Anwendung und die Renaissance der Liposomen
Attendees from over 20 countries joined our virtual Scientific Drug Delivery Conference 2022 on Tuesday 15th February to learn about topics specifically related to drug delivery, about nanotechnology and 3D printing. We would like to express our heartfelt thanks to each of the speakers as well as to the participants who gave their time to attend and to contribute.
Only two weeks left - REGISTER now for our #Livestream : 4th Drug Delivery Conference on February 15th | #drugdelivery #nanotechnology #3Dprinting #pharma
Teil 2 der spannenden Story über die Einführung der Nanotechnologie bei Losan Pharma
Von der zündenden Idee bis zu den ersten Versuchen mit Nanosuspensionen: Am Anfang stand das Problem, neue Formulierungen für Arzneimittel mit sehr geringen Mengen an schwerlöslichen Wirkstoffen zu entwickeln. Hier erfahren Sie mehr über unsere Versuche mit Wirkstoff-Nanopartikeln und über unseren Beitrag zur Entwicklung einer dualen Zentrifuge.
New Losan Pharma whitepaper available
Outsourcing Drug Development & Production: Technology-Driven Drug Delivery Systems for Small Molecules at Losan Pharma
Rapid development of API nano-formulations from screening to production combining dual centrifugation and wet agitator bead milling.
International Journal of Pharmaceutics, 30 June 2019